Using a Targeted Cancer Vaccine (Galinpepimut-S) With Immunotherapy (Nivolumab) in Mesothelioma

Clinical trial NCT04040231 · COMPLETED

Trial details

NCT number: NCT04040231
Sponsor: Memorial Sloan Kettering Cancer Center
Status: COMPLETED
Phase: Phase 1
Study type: INTERVENTIONAL

Mesothelioma Pleural Mesothelioma Wilms Tumor

Start date: 2019-07-24
Primary completion: 2024-11-14
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.